REHOVOT, Israel, Sept. 15, 2025 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics,...
CollPlant Expands the Distribution of its VergenixSTR Product in Europe
Seeking Alpha / 9 hours ago 1 Views
Comments